Explore more publications!

Healthcare Wire Hong Kong: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Hong Kong.

Press releases published on April 15, 2026

Vivos Therapeutics Reports Full Year 2025 Financial Results
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
Teladoc Health to Announce First Quarter 2026 Financial Results
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
Wave Life Sciences Announces Proposed Redomiciliation to the United States
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation
Elion Therapeutics Announces Initiation of Turletricin (EL219) Phase 2 Study in Invasive Mould Infection
Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026
The Association for Frontotemporal Degeneration (AFTD) Hosts First Capitol Hill Briefing: “Frontotemporal Degeneration: Shining a Light on a Little-Known Dementia”
Svetlana Mojsov, one of the Scientists behind Ozempic, and Mathematician Carlos Kenig, who Decoded Laws of Motion, Honored as King Faisal Prize 2026 Laureates
Shingles Raises Heart and Stroke Risk: Protect Yourself with Vaccination
Running with Purpose: Nashville Podiatrist Dr. Lanier Shares Expert Tips for Injury-Free Half Marathon Training
Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer
AssureCKD Appoints Former LumiraDx Technical Director Dr. Aman Khan as Chief Technology Officer to Lead Diagnostic Platform Development
Basilea-Aktionäre genehmigen an der Generalversammlung 2026 alle Anträge des Verwaltungsrats
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions